I, for one, am very glad we have moved on from Amarex and now are totally clear of all that the FDA had objections to, namely, not LL, but the makeup of our former administration.

We seem to moving very swiftly toward getting LL out there and Dr. JL in just a few short months has us going completely in the right direction. Looking forward to publishing and partnerships. Thanks to the mods for keeping this board positive, everything else seems counter productive.